• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [24642 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Economic evaluation of drug eluting stents in the treatment of ischemic heart disease (update)]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Cost effectiveness of different types of coronary stents which are used in patients with acute coronary syndrome (ACS)]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Efficacy, safety and economic assessment of the percutaneous aortic valve implantation]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Standards for the appropriate use of health technologies: diagnostic colonoscopy ]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Economic evaluation of photoselective vaporization treatment for benign prostatic hyperplasia]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Patient decision aids tool for breast cancer]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review of the effectiveness of the stereoscopic vision systems for minimally invasive surgery]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review of efficacy and economic impact of genetic tests in breast cancer and depression treatment]
2010     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Key factors in Electronic Clinical Guides: Breast Cancer]
2003     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) Efficacy, effectiveness and safety of drug eluting stents
2003     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) Effectiveness and safety of cryosurgery for prostate cancer
2003     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus: indications
2003     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) Botulinum toxin: indications, costs, and situation in other communities in Spain
1999     Unidad De Tecnologias De Salud (ETESA) Rational use of colloid solutions. Part I
2007     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Infliximab in patients with arthritis psoriatic: systematic review of the clinical and economic literature]
2007     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Parenteral methotrexate in patients with rheumatoid arthritis: systematic review, crossectional study and economic evaluation]
2007     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Economic evaluation of the first TNF-alpha inhibitor therapy in patients with rheumatoid arthritis]
2007     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Abatacept in the treatment of rheumatoid arthritis; systematic review and economic evaluation]
2001     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) Breast and gynaecological cancer screening in Hungary: Cost effectiveness analysis, (in: Dorossy L, Organised screening in oncology; Guidebook in quality improvement and methodology)
2006     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Rituximab in patients with rheumatoid arthritis:systematic review and economic evaluation]
2006     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Etanercept in patients with juvenile idiopathic arthritis: systematic review and economic evaluation]
2006     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Biologicals in patients with spondylitis ankylopoetica; the (REMICADE) therapy]
2006     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Paclitaxel-Eluting Coronary Stent System in cardiovascular treatment; systematic review of the clinical and economic literature]
2006     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Health economics modelling: costs, effectiveness and cost-effectiveness of biological agents in rheumatoid arthritis with particular emphasis on infliximab (REMICADE) therapy]
2005     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Clinical effectiveness of carvedilol in comparison to -blockers, systematic review of the clinical and economic literature]
2005     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Biologicals in patients with psoriasis, infliximab (REMICADE) therapy]
2005     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Clinical effectiveness of indapamide; systematic review of the clinical and economic literature]
2002     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [DMARD therapy of rheumatoid arthritis, systematic review of the clinical and economic literature]
2003     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Epidemiology and costs of osteoarthritis and rheumatoid arthritis in Hungary]
2004     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [The most often used androgen receptor blockers (flutamide, bicalutamide, nilutamide) in prostate cancer; systematic review of the clinical and economic literature]
2004     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Infliximab (REMICADE) in patients with rheumatoid arthritis; systematic review of the clinical and economic literature]
2001     University HealthSystem Consortium (UHC) Tegaserod (Zelmac) (irritable bowel syndrome)
2001     University HealthSystem Consortium (UHC) Parenteral radiopaque contrast media
2005     University HealthSystem Consortium (UHC) Absorbable hemostatic agents
2005     University HealthSystem Consortium (UHC) Alvimopan
2005     University HealthSystem Consortium (UHC) Drotrecogin update
2005     University HealthSystem Consortium (UHC) Eszopiclone
2005     University HealthSystem Consortium (UHC) Exenatide
2005     University HealthSystem Consortium (UHC) Fluoroquinolones update
2005     University HealthSystem Consortium (UHC) HMG-CoA reductase inhibitors
2005     University HealthSystem Consortium (UHC) Inhaled anesthetic agents
2005     University HealthSystem Consortium (UHC) Low-molecular weight heparins update
2005     University HealthSystem Consortium (UHC) Lung surfactants update
2005     University HealthSystem Consortium (UHC) Natalizumab
2005     University HealthSystem Consortium (UHC) Neuromuscular blocking agents update
2005     University HealthSystem Consortium (UHC) Palifermin
2005     University HealthSystem Consortium (UHC) Pramlintide acetate
2005     University HealthSystem Consortium (UHC) Prasterone
2004     University HealthSystem Consortium (UHC) 5-HT3 antagonist update (2004)
2004     University HealthSystem Consortium (UHC) ACE inhibitors update
2004     University HealthSystem Consortium (UHC) Agents for multiple sclerosis (TCR)
2004     University HealthSystem Consortium (UHC) Aromatase inhibitors (TCR)
2004     University HealthSystem Consortium (UHC) Biologic agents for psoriasis
2004     University HealthSystem Consortium (UHC) Cinacalcet hydrochloride
2004     University HealthSystem Consortium (UHC) Daptomycin
2004     University HealthSystem Consortium (UHC) Gadolinium based contrast media
2004     University HealthSystem Consortium (UHC) Iodinated radiocontrast agents
2004     University HealthSystem Consortium (UHC) Levalbuterol hydrochloride update
2004     University HealthSystem Consortium (UHC) Memantine
2004     University HealthSystem Consortium (UHC) Oblimersen sodium (Genasense)
2004     University HealthSystem Consortium (UHC) Oregovomab
2004     University HealthSystem Consortium (UHC) Rasagiline
2003     University HealthSystem Consortium (UHC) Adefovir dipivoxil for treatment of hepatitis B
2003     University HealthSystem Consortium (UHC) Agents for pulmonary hypertension (TCR)
2003     University HealthSystem Consortium (UHC) Aripiprazole
2003     University HealthSystem Consortium (UHC) Atypical antipsychotics - update (TCR)
2003     University HealthSystem Consortium (UHC) Bortezomib
2003     University HealthSystem Consortium (UHC) Carbapenems
2003     University HealthSystem Consortium (UHC) Enfuvirtide
2003     University HealthSystem Consortium (UHC) Eplerenone
2003     University HealthSystem Consortium (UHC) Gene therapy
2003     University HealthSystem Consortium (UHC) HMG-CoA reductase inhibitors
2003     University HealthSystem Consortium (UHC) Immune globulin intravenous (IGIV) (TCR)
2003     University HealthSystem Consortium (UHC) Inhaled insulins (TCR)
2003     University HealthSystem Consortium (UHC) Oral and intravenous antifungal agents - update (TCR)
2003     University HealthSystem Consortium (UHC) Oxaliplatin
2003     University HealthSystem Consortium (UHC) Ranolazine
2003     University HealthSystem Consortium (UHC) Zevalin
2001     University HealthSystem Consortium (UHC) Smoking cessation therapies
2001     University HealthSystem Consortium (UHC) Proton pump inhibitors update
2001     University HealthSystem Consortium (UHC) Fluoroquinolones update
2001     University HealthSystem Consortium (UHC) Drotrecogin alfa
2001     University HealthSystem Consortium (UHC) Options for osteoporosis
2001     University HealthSystem Consortium (UHC) Oxcarbazepine
2001     University HealthSystem Consortium (UHC) SSRIs
2001     University HealthSystem Consortium (UHC) Antiparkinson agents
2001     University HealthSystem Consortium (UHC) Lung surfactants update
2001     University HealthSystem Consortium (UHC) Argatroban
2001     University HealthSystem Consortium (UHC) Novel erythropoiesis stimulating protein
2001     University HealthSystem Consortium (UHC) Glycoprotein IIb/IIIa receptor antagonists revised
2001     University HealthSystem Consortium (UHC) 5-HT3 antagonists update
2001     University HealthSystem Consortium (UHC) Hormone replacement therapy options
2001     University HealthSystem Consortium (UHC) Omapatrilat
2001     University HealthSystem Consortium (UHC) Liposomal amphotericin update
2002     University HealthSystem Consortium (UHC) Sedative/hypnotics
2002     University HealthSystem Consortium (UHC) Alzheimer's
2002     University HealthSystem Consortium (UHC) Fondaparinux
2002     University HealthSystem Consortium (UHC) Ziconotide
2002     University HealthSystem Consortium (UHC) Imatinib mesylate (Gleevec)
2002     University HealthSystem Consortium (UHC) Bosentan (Tracleer)